Tzipora Strauss at ARDD2025: SHARP Study at Sheba Longevity Center

Tzipora Strauss at ARDD2025: SHARP Study at Sheba Longevity Center

🎙 Tzipora Strauss 👥 9K 📅 January 16, 2026 ⏱ 22 min 👁 368 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

biological ageaging clockSHARP studylongevity clinicmortality risk

Summary

Tzipora Strauss presents the SHARP study, a randomized controlled trial conducted at the Sheba Longevity Center in Israel. The study enrolls healthy individuals aged 50 and above who undergo a comprehensive longevity assessment day, including blood tests, epigenetic clocks, brain imaging, physical performance, and more. Participants are randomized to receive their results and follow-up (intervention) or not (control). Preliminary results show that the intervention group had a slight reduction in biological age after 6 and 12 months compared to controls, and 54% of the intervention group showed rejuvenation. The study also identified correlations between younger biological age and better body composition, physical fitness, balance, and sleep. Additionally, Strauss presents retrospective data from an executive screening program with 2,597 participants followed for 15 years, showing that accelerated aging (biological age older than chronological) is associated with higher mortality, and that the pace of aging (change in biological age over time) predicts mortality and hospitalization. A practical clinical tool is proposed: a delta of 4 years between biological and chronological age indicates a 50% increased mortality risk. The study aims to integrate biological age into routine clinical practice.

186 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable preliminary data from a real-world clinical implementation of biological age assessment. The SHARP study is a randomized controlled trial, which is a strong design, and the retrospective cohort analysis adds longitudinal depth. The argumentation is logical, moving from associations to intervention effects and then to predictive validity for mortality. However, the results are preliminary and not yet peer-reviewed, and the presenter acknowledges ongoing recruitment. The use of biological age as a clinical tool is compelling, but the presenter does not deeply discuss limitations such as the choice of aging clock, potential confounding, or generalizability. The argument that biological age remains significant after adjusting for comorbidities is a key point, but the analysis is not fully detailed.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous in its methodology, with clear inclusion criteria, randomization, and statistical analyses (Cox regression). The sources are primarily the study’s own data, and no external references are cited. The title accurately reflects the content. The presenter does not mention any external sources, and the description provides no links. The lack of peer review and the preliminary nature of the results are limitations, but the study design and data collection are thorough.

210 words

Title / Content Match

The title accurately reflects the content: a presentation of the SHARP study at the Sheba Longevity Center.

Quality & Reliability

8/10

Presentation of preliminary results from an ongoing clinical study at a major medical center, with clear methodology and statistical analyses, but not yet peer-reviewed.

Key Moments

Contribution & Novelties

The SHARP study is one of the first to implement biological age assessment in a public hospital setting, providing real-world data on the feasibility and impact of such interventions. The retrospective analysis linking pace of aging to mortality and hospitalization is a novel contribution, as is the proposal of a practical clinical threshold (delta of 4 years) for risk stratification. The study also highlights the importance of lifestyle factors such as sleep, balance, and visceral fat in biological aging.

Pour aller plus loin :

106 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and reliability, with a slightly lower technical level, indicating a presentation that is data-rich and credible but not overly technical.

Reliability 8/10